Yanamala, Naveena Gardner, Eric Riciutti, Alec Klein-Seetharaman, Judith
Published in
Current drug targets
The mammalian dim-light photoreceptor rhodopsin is a prototypic G protein coupled receptor (GPCR), interacting with the G protein, transducin, rhodopsin kinase, and arrestin. All of these proteins interact with rhodopsin at its cytoplasmic surface. Structural and modeling studies have provided in-depth descriptions of the respective interfaces. Ove...
Yamagishi, Sho-ichi
Published in
Current drug targets
Recent meta-analyses have revealed that the risk of bone fracture is increased in both type 1 and type 2 diabetic patients. Low bone mineral density (BMD) can not necessarily explain the link, because BMD is increased rather than decreased in type 2 diabetes, while it is consistently low in type 1 diabetes subjects. Although multiple factors could ...
Epifano, Francesco Curini, Massimo Marcotullio, Maria Carla Genovese, Salvatore
Published in
Current drug targets
The genus Zanthoxylum (Rutaceae) comprises about 250 species, of which many are used as food, often as condiments, substituting pepper due to the pungent taste of fruits, seeds, leaves, and bark, and therapeutic remedies especially in Eastern Asian countries and in Central America. The whole plant is also consumed as an ingredient of soups and sala...
Nikolopoulos, Georgios K Bagos, Pantelis G Bonovas, Stefanos
Published in
Current drug targets
Meta-analysis is a quantitative approach for systematically combining the results of previous studies in order to arrive at conclusions about the body of research. It answers a specific research question, includes an explicit methodology section, employs strategies to minimize bias, yields objective findings and enables evidence-based decisions. In...
Yap, Timothy A Sandhu, Shahneen K Alam, Salma M de Bono, Johann S
Published in
Current drug targets
The hepatocyte growth factor/mesenchymal-epithelial transition factor (HGF/c-MET) receptor tyrosine kinase (RTK) pathway plays a pleotropic role in cell proliferation, migration, invasion, angiogenesis and survival. Although it has critical physiological functions in embryonic development and tissue repair, this signaling cascade is frequently dere...
Weiss, Glen J Mita, Alain C Von Hoff, Daniel D
Published in
Current drug targets
Contrary to the Classical Greek poet Archilochus' phrase "The fox knows many things but the hedgehog knows one big thing", the Hedgehog (HH) signaling pathway knows at least 3 ways to promote or support carcinogenesis. In this review, we provide a summary of the HH signaling pathway, and detail the clinical relevance and treatment of patients. Fina...
Giles, Francis J
Published in
Current drug targets
Mahalingam, Devalingam Oldenhuis, Corina N A M Szegezdi, Eva Giles, Francis J de Vries, Elisabeth G E de Jong, Steven Nawrocki, Steffan T
Published in
Current drug targets
Tumor necrosis factor-related apoptosis-inducing ligand or Apo2 ligand (TRAIL/Apo2L) is a member of the tumor necrosis factor (TNF) superfamily that induces apoptosis upon binding to its death domain-containing transmembrane receptors. The preferential toxicity of TRAIL to cancer cells and the sparing of normal cells make it an ideal cancer therape...
Sandhu, Shahneen K Yap, Timothy A de Bono, Johann S
Published in
Current drug targets
Poly(ADP-ribose) polymerase (PARP) is a critical DNA repair enzyme involved in DNA single-strand break repair via the base excision repair pathway. PARP inhibitors have been shown to sensitize tumors to DNA-damaging agents and to also selectively kill homologous recombination repair-defective cancers, such as those arising in BRCA1 and BRCA2 mutati...
Kelly, Kevin R Ecsedy, Jeffrey Mahalingam, Devalingam Nawrocki, Steffan T Padmanabhan, Swaminathan Giles, Francis J Carew, Jennifer S
Published in
Current drug targets
The Aurora family of serine/threonine kinases is essential for chromosome alignment, segregation, centrosomal maturation, mitotic spindle formation, and cytokinesis during mitosis. Their fundamental role in cell cycle regulation and aberrant expression in a broad range of malignancies prompted the development of small molecules that selectively inh...